Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 11.040\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CCCCOc1ccc(C(O)C(CN2CCCCC2)c2ccccc2)cc1
b COc1ccc(S(=O)(=O)N2c3ccccc3OCC2c2ccccc2)cc1
c CCn1c2ccccc2c2cc(N=C3SC(CC(=O)Nc4ccccc4)C(=O)N3C)ccc21
d Cc1sc2ncnc(OCC(=O)Nc3ccc4c(c3)OCCO4)c2c1C
Answer: d. Cc1sc2ncnc(OCC(=O)Nc3ccc4c(c3)OCCO4)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1sc2ncnc(OCC(=O)Nc3ccc4c(c3)OCCO4)c2c1C
Cc1sc2ncnc(OCC(=O)Nc3ccc4c(c3)OCCO4)c2c1C
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)oxyacetamide